[Pulmonary pressure-flow relationship following pulmonary microembolism: preventive therapy with heparin and acetylsalicylic acid/dipyridamole].
D000818:Animals; D001241:Aspirin / Q000627:therapeutic use*; D001794:Blood Pressure; D002302:Cardiac Output / Q000187:drug effects; D002986:Clinical Trials as Topic; D004176:Dipyridamole / Q000627:therapeutic use*; D004285:Dogs; D005340:Fibrinogen / Q000032:analysis; D006493:Heparin / Q000627:therapeutic use*; D008168:Lung / Q000473:pathology; D010974:Platelet Aggregation / Q000187:drug effects; D011652:Pulmonary Circulation; D011655:Pulmonary Embolism / Q000503:physiopathology* / Q000517:prevention & control; D012771:Shock, Hemorrhagic / Q000503:physiopathology; D014655:Vascular Resistance
D004176:Dipyridamole; D005340:Fibrinogen; D006493:Heparin; D001241:Aspirin
Pulmonale Druck-Fluss-Relation nach pulmonaler Mikroembolie: Prophylaktische Therapie mit Heparin und Acetylsalizylsäure/Dipyridamol.